<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Cayman Journal - Opus Genetics Inc (IRD)</title>
    <description>Latest news, press releases, and SEC filings for Opus Genetics Inc (IRD)</description>
    <link>https://caymanjournal.com/stock/IRD</link>
    <language>en-us</language>
    
    <copyright>Copyright 2026, Cayman Journal</copyright>
    <managingEditor>editorial@caymanjournal.com (Editorial Team)</managingEditor>
    <webMaster>webmaster@caymanjournal.com (Web Master)</webMaster>
    <lastBuildDate>Tue, 28 Apr 2026 02:32:16 GMT</lastBuildDate>
    <ttl>60</ttl>
    <atom:link href="https://caymanjournal.com/stock/IRD/feed.xml" rel="self" type="application/rss+xml" />
    <image>
      <url>https://caymanjournal.com/logo.png</url>
      <title>Cayman Journal</title>
      <link>https://caymanjournal.com</link>
      <width>144</width>
      <height>144</height>
    </image>

    <item>
      <title>S-3/A — Opus Genetics, Inc.</title>
      <description># 🧾 What This Document Is 📄

This document is an Amendment to Form S-3, which is a legal filing with the SEC (Securities and Exchange Commission). Think of this form as a detailed instruction manual that Opus Genetics is providing to potential investors before they buy the company&apos;s stock.

The co</description>
      <link>https://caymanjournal.com/stock/IRD/sec-filing/0001140361-26-015733</link>
      <guid isPermaLink="true">https://caymanjournal.com/stock/IRD/sec-filing/0001140361-26-015733</guid>
      <pubDate>Tue, 21 Apr 2026 00:00:00 GMT</pubDate>
      
      <category>SEC Filing</category>
      
    </item>
  </channel>
</rss>